Valeritas To Present At The Canaccord Medical Technologies & Diagnostic Forum

BRIDGEWATER, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer and Erick Lucera, Chief Financial Officer are scheduled to present at the Canaccord Medical Technologies & Diagnostic Forum.
Event: Canaccord Medical Technologies & Diagnostic Forum
Format: Presentation and One-on-One Meetings
Date: Thursday, November 17, 2016
Time: 1:30pm ET
Location: New York, NY

Audio webcasts of the Company's presentation will be available by visiting the investor relations section of the Valeritas website at Replays of the presentation will be available for 90 days.

About Valeritas Holdings, Inc.Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas' flagship product, V-Go ® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes.  It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit
Investor Contacts:Nick Laudico / Robert Flamm, Ph.D.The Ruth Group(646)536-7030 / 7017IR@valeritas.comOrThe Del Mar Consulting Group, Inc.Robert B. Prag, President858-794-9500bprag@delmarconsulting.comMedia Contact:Christopher HippolyteThe Ruth Group(646)

If you liked this article you might like

Tuesday's Health Winners & Losers
Indevus Buying Valera

Indevus Buying Valera